143 related articles for article (PubMed ID: 17264447)
1. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Sood A; Midha V; Bansal M; Goyal A; Sharma N
Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
[No Abstract] [Full Text] [Related]
2. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
Farshidi D; Chiu MW
J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
[No Abstract] [Full Text] [Related]
3. Tongue hyperpigmentation during hepatitis C treatment.
Bachmeyer C; Pellen JC
CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
[No Abstract] [Full Text] [Related]
4. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Radha Krishna Y; Itha S
Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
[No Abstract] [Full Text] [Related]
5. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
Torres HA; Bull L; Arduino RC; Barnett BJ
Am J Gastroenterol; 2007 Jun; 102(6):1334-5. PubMed ID: 17531028
[No Abstract] [Full Text] [Related]
6. A surprising hyperpigmentation of the gums and tongue.
Dell'Isola S; Ialungo AM; Starnini G; Roselli P; Ghittoni G; Caturelli E
Gut; 2008 Dec; 57(12):1697, 1727. PubMed ID: 19022927
[No Abstract] [Full Text] [Related]
7. Tongue hyperpigmentation during interferon therapy.
Karabay O; Goksugur N; Ogutlu A
J Dermatol; 2011 Mar; 38(3):290-1. PubMed ID: 21342236
[No Abstract] [Full Text] [Related]
8. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report.
de Moraes PC; Noce CW; Thomaz LA; Mautoni MC; Corrêa ME
J Am Dent Assoc; 2009 Nov; 140(11):1377-9. PubMed ID: 19884395
[TBL] [Abstract][Full Text] [Related]
9. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
[No Abstract] [Full Text] [Related]
10. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.
Ghosh S; Duseja A; Dhiman RK; Chawla YK
Dig Dis Sci; 2012 Mar; 57(3):820-1. PubMed ID: 21948358
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Lin J; Lott JP; Amorosa VK; Kovarik CL
J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
[No Abstract] [Full Text] [Related]
12. [Lingual hyperpigmentation in a patient with chronic infection].
López Peláez MV; González Díaz P; Téllez Molina MJ; Vergas García J
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):264-5. PubMed ID: 23260387
[No Abstract] [Full Text] [Related]
13. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
Willems M; Munte K; Vrolijk JM; Den Hollander JC; Böhm M; Kemmeren MH; De Man RA; Brouwer JT
Br J Dermatol; 2003 Aug; 149(2):390-4. PubMed ID: 12932249
[TBL] [Abstract][Full Text] [Related]
14. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
Ku JY; Sharma A
Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
[No Abstract] [Full Text] [Related]
15. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
[No Abstract] [Full Text] [Related]
16. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
Golstein PE; Delforge ML; Deviere J; Marcellin P
J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
[TBL] [Abstract][Full Text] [Related]
17. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
18. [Severe ocular bacterial infection associated with pegylated interferon and ribavirin treatment for hepatitis C].
Khalil A; Gonzalez F; El Riachy E; Lucidarme D; Filoche B
Gastroenterol Clin Biol; 2005 Nov; 29(11):1187-8. PubMed ID: 16505773
[No Abstract] [Full Text] [Related]
19. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
Ortega-Ibarra FS; Remes-Troche JM
Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
[No Abstract] [Full Text] [Related]
20. Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.
Adişen E; Dizbay M; Hizel K; Ilter N
Indian J Dermatol Venereol Leprol; 2008; 74(1):60-2. PubMed ID: 18187830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
